HD 21 (#613)
Laufzeit: 01.01.2016 - 31.12.2040
Kurzfassung
Treatment optimization trial in the first-line treatment of advanced stage Hodgkin's lymphoma; comparison of 6 cycles of escalated BEACOPP with 6 cycles of BrECADD
Laufzeit: 01.01.2016 - 31.12.2040
Treatment optimization trial in the first-line treatment of advanced stage Hodgkin's lymphoma; comparison of 6 cycles of escalated BEACOPP with 6 cycles of BrECADD
